Patents by Inventor Cecilia Oderda

Cecilia Oderda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymer conjugates of K-252A and derivatives thereof
    Patent number: 8673347
    Abstract: The present invention relates to novel polymer conjugates of K-252a and derivatives thereof and to their use for the preparation of a pharmaceutical composition useful for the prevention, alleviation and treatment of kinase-associated pathologies. In particular, the present invention relates to the prevention, alleviation and treatment of HMGB1-associated pathologies. The invention relates to the use of the novel polymer conjugates of K-252a and derivatives thereof in the preparation of a pharmaceutical composition useful for the prevention, alleviation and treatment of a) neurological disorders, neuropathies and neurodegenerative disorders of the central and peripheral nervous system; b) dermal pathologies, in particular dermal pathologies associated with an excessive keratinocyte proliferation, in particular psoriasis; and c) NGF-related pain.
    Type: Grant
    Filed: August 25, 2006
    Date of Patent: March 18, 2014
    Assignee: Creabilis Therapeutics S.p.A.
    Inventors: Silvio Traversa, Raffaella Bagnod, Domenico Barone, Luisa Bertarione Rava Rossa, Silvano Fumero, Valentina Mainero, Alessandra Marconi, Cecilia Oderda, Carlo Pincelli, Chiara Lorenzetto, Luca Beccaria
  • Polymer Conjugates of K-252A and Derivatives Thereof
    Publication number: 20080193517
    Abstract: The present invention relates to novel polymer conjugates of K-252a and derivatives thereof and to their use for the preparation of a pharmaceutical composition useful for the prevention, alleviation and treatment of kinase-associated pathologies. In particular, the present invention relates to the prevention, alleviation and treatment of HMGB1-associated pathologies. In a particular aspect, the invention relates to the use of the novel polymer conjugates of K-252a and derivatives thereof in the preparation of a pharmaceutical composition useful for the prevention, alleviation and treatment of neurological disorders, neuropathies and neurodegenerative disorders of the central and peripheral nervous system.
    Type: Application
    Filed: August 25, 2006
    Publication date: August 14, 2008
    Applicant: CREABILIS THERAPEUTICS S.P.A.
    Inventors: Silvio Traversa, Raffaella Bagnod, Domenico Barone, Luisa Bertarione Rava Rossa, Silvano Fumero, Valentina Mainero, Alessandra Marconi, Cecilia Oderda, Carlo Pincelli, Chiara Lorenzetto, Luca Beccaria